Seeing Is Believing

Currently out of the existing stock ratings of Jessica Fye, 130 are a HOLD (35.62%), 207 are a BUY (56.71%), 28 are a SELL (7.67%).
Analyst Jessica Fye, currently employed at JPMORGAN, carries an average stock price target met ratio of 75.51% that have a potential upside of 28.09% achieved within 216 days.
Jessica Fye’s has documented 698 price targets and ratings displayed on 55 stocks. The coverage is on Healthcare, Energy, Industrials, Technology sectors.
Most recent stock forecast was given on INCY, yte at 23-Jul-2026.
Analyst best performing recommendations are on APRE (APREA THERAPEUTICS).
The best stock recommendation documented was for ESPR (ESPERION THERAPEUTICS) at 5/3/2018. The price target of $41 was fulfilled within 1 day with a profit of $4.07 (11.02%) receiving and performance score of 110.21.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 19-Oct-2022
$12
$-3.91 (-24.58%)
$800
9 months ago
(30-Oct-2025)
2/4 (50%)
$-4.4 (-26.83%)
1055
Buy Since 16-Apr-2021
2 years 1 months 10 days ago
(20-Jun-2024)
12/26 (46.15%)
$-53.8 (-84.33%)
1398
Sell Since 06-May-2022
2 years 8 months 10 days ago
(20-Nov-2023)
0/2 (0%)
$1519.2 (1880.20%)
Buy Since 25-Oct-2023
$20
$5.52 (38.12%)
2 years 9 months 5 days ago
(25-Oct-2023)
1/17 (5.88%)
$5.8 (40.85%)
77
Hold Since 19-Jul-2023
$25
$10.52 (72.65%)
3 years 11 days ago
(19-Jul-2023)
1/2 (50%)
$3.4 (15.74%)
175
Which stock is Jessica Fye is most bullish on?
Which stock is Jessica Fye is most reserved on?
What Year was the first public recommendation made by Jessica Fye?